{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:46:06Z","timestamp":1788547566534,"version":"build-2803163510"},"reference-count":44,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2002,12,11]],"date-time":"2002-12-11T00:00:00Z","timestamp":1039564800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Human Psychopharmacology"],"published-print":{"date-parts":[[2003,4]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Paroxetine is a potent selective serotonin reuptake inhibitor (SSRI) with indications for the treatment of depression, obsessive\u2013 compulsive disorder, panic disorder and social phobia. It is also used in the treatment of generalized anxiety disorder, post\u2010traumatic stress disorder, premenstrual dysphoric disorder and chronic headache. There is wide interindividual variation in the pharmacokinetics of paroxetine in adults as well as in the elderly with higher plasma concentrations and slower elimination noted in the latter. Elimination is also reduced in severe renal and hepatic impairment, however, serious adverse events are extremely rare even in overdose. A Pub Med search was used to collect information on the efficacy and tolerability in elderly patients. There are few studies of depression in the elderly and only one study in the old\u2013old. In anxiety disorders including general anxiety disorder, panic disorder, obsessive\u2013compulsive disorder and social anxiety, there are no studies at all in the elderly. However, the safety of the drug allows its prescription in the elderly. In summary, paroxetine is well tolerated in the treatment of depression in those between the ages of 65 and 75, although few studies have examined its use in those of 75 and older. Copyright \u00a9 2002 John Wiley &amp; Sons, Ltd.<\/jats:p>","DOI":"10.1002\/hup.467","type":"journal-article","created":{"date-parts":[[2003,3,28]],"date-time":"2003-03-28T12:22:50Z","timestamp":1048854170000},"page":"185-190","source":"Crossref","is-referenced-by-count":20,"title":["Use of paroxetine for the treatment of depression and anxiety disorders in the elderly: a review"],"prefix":"10.1002","volume":"18","author":[{"given":"Michel","family":"Bourin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2002,12,11]]},"reference":[{"key":"e_1_2_1_2_1","first-page":"165","article-title":"Changes on the temperament and character inventory after paroxetine treatment in volunteers with generalized anxiety disorder","volume":"34","author":"Allgulander C","year":"1998","journal-title":"Psychopharmacol Bull"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.175.2.120"},{"key":"e_1_2_1_4_1","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.155.1.36"},{"key":"e_1_2_1_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1527-3458.2001.tb00189.x"},{"key":"e_1_2_1_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0278-5846(98)00009-8"},{"key":"e_1_2_1_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004583-199503000-00006"},{"key":"e_1_2_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/1520-6394(2001)13:1<38::AID-DA6>3.0.CO;2-7"},{"key":"e_1_2_1_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1520-6394(1997)6:3<113::AID-DA4>3.0.CO;2-E"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1002\/da.10014"},{"key":"e_1_2_1_11_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n0504"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002130000588"},{"key":"e_1_2_1_13_1","doi-asserted-by":"publisher","DOI":"10.1159\/000139327"},{"key":"e_1_2_1_14_1","first-page":"48","article-title":"Therapeutic considerations in treating depression in the elderly","volume":"55","author":"Dunner DL","year":"1994","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02246291"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0167-4943(96)00725-X"},{"key":"e_1_2_1_17_1","volume-title":"Manic\u2010depressive Illness","author":"Goodwin FK","year":"1990"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07192.x"},{"key":"e_1_2_1_19_1","first-page":"43","article-title":"A double blind study in general practice to compare the efficacy and tolerability of paroxetine and amitriptyline in depressed elderly patients","volume":"2","author":"Hutchinson DR","year":"1992","journal-title":"Br J Clin Res"},{"key":"e_1_2_1_20_1","doi-asserted-by":"publisher","DOI":"10.1097\/00019442-199621420-00009"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1099-1166(199802)13:2<100::AID-GPS738>3.0.CO;2-J"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.1992.01820100053010"},{"key":"e_1_2_1_23_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.159.4.531"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1989.tb07177.x"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v57n1103"},{"key":"e_1_2_1_26_1","doi-asserted-by":"publisher","DOI":"10.1159\/000054920"},{"key":"e_1_2_1_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199609000-00003"},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0165-0327(97)00107-9"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200219050-00006"},{"issue":"20","key":"e_1_2_1_30_1","first-page":"16","article-title":"A double\u2010blind randomized comparison of nortriptyline and paroxetine in the treatment of late\u2010life depression: 6\u2010week outcome","volume":"60","author":"Mulsant BH","year":"1999","journal-title":"J Clin Psychiat"},{"key":"e_1_2_1_31_1","first-page":"26","article-title":"Dual\u2010task performance in depressed geriatric patients","volume":"60","author":"Nebes RD","year":"1999","journal-title":"J Clin Psychiat"},{"key":"e_1_2_1_32_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.167.3.374"},{"key":"e_1_2_1_33_1","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0508"},{"key":"e_1_2_1_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0893-133X(00)00132-9"},{"issue":"5","key":"e_1_2_1_35_1","first-page":"S2","article-title":"Recent pharmacologic advances in antidepressant therapy for the elderly","volume":"94","author":"Preskorn SH","year":"1993","journal-title":"AJM"},{"key":"e_1_2_1_36_1","doi-asserted-by":"publisher","DOI":"10.1177\/026988119801200404"},{"key":"e_1_2_1_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1997.tb09660.x"},{"issue":"1","key":"e_1_2_1_38_1","first-page":"S51","article-title":"Pharmacological considerations in the treatment of late\u2010life depression","volume":"4","author":"Schneider LS","year":"1996","journal-title":"Am J Geriat Psychiat"},{"key":"e_1_2_1_39_1","first-page":"184","article-title":"Sudden recovery from depression under treatment with paroxetine","volume":"10","author":"Schnyder U","year":"1996","journal-title":"Eur J Psychiat"},{"key":"e_1_2_1_40_1","first-page":"S34","article-title":"A double blind study of paroxetine compared with fluoxetine in geriatric patients with major depression","volume":"13","author":"Sch\u00f6ne W","year":"1993","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_1_41_1","first-page":"620","volume-title":"Comprehensive Review of Geriatric Psychiatry","author":"Sheikh J","year":"1996"},{"key":"e_1_2_1_42_1","first-page":"402","article-title":"A double\u2010blind placebo\u2010controlled trial of paroxetine in management of social phobia (social anxiety disorder) in South Africa","volume":"89","author":"Stein DJ","year":"1999","journal-title":"SAMJ"},{"key":"e_1_2_1_43_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199606000-00005"},{"key":"e_1_2_1_44_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2125.1999.00872.x"},{"key":"e_1_2_1_45_1","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.169.4.468"}],"container-title":["Human Psychopharmacology: Clinical and Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fhup.467","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/hup.467","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T03:05:45Z","timestamp":1700276745000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/hup.467"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,12,11]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,4]]}},"alternative-id":["10.1002\/hup.467"],"URL":"https:\/\/doi.org\/10.1002\/hup.467","archive":["Portico"],"relation":{},"ISSN":["0885-6222","1099-1077"],"issn-type":[{"value":"0885-6222","type":"print"},{"value":"1099-1077","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,12,11]]}}}